These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34015556)

  • 1. Audio-digital recordings to assess ratings reliability in clinical trials of schizophrenia.
    Targum SD; Pendergrass JC; Murphy C
    Schizophr Res; 2021 Jun; 232():54-60. PubMed ID: 34015556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-independent confirmation of primary site-based PANSS ratings in a schizophrenia trial.
    Targum SD; Murphy C; Breier A; Brannan SK
    J Psychiatr Res; 2021 Dec; 144():241-246. PubMed ID: 34700212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of BPRS interview length on ratings reliability in a schizophrenia trial.
    Targum SD; Cara Pendergrass J; Toner C; Zumpano L; Rauh P; DeMartinis N
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):312-8. PubMed ID: 25554563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Audio-digital recordings for surveillance in clinical trials of major depressive disorder.
    Targum SD; Catania CJ
    Contemp Clin Trials Commun; 2019 Jun; 14():100317. PubMed ID: 30705991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equipercentile linking of the BPRS and the PANSS.
    Leucht S; Rothe P; Davis JM; Engel RR
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):956-9. PubMed ID: 23433639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Positive and Negative Syndrome Scale and the Brief Psychiatric Rating Scale. Reliability, comparability, and predictive validity.
    Bell M; Milstein R; Beam-Goulet J; Lysaker P; Cicchetti D
    J Nerv Ment Dis; 1992 Nov; 180(11):723-8. PubMed ID: 1431824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linking the PANSS, BPRS, and CGI: clinical implications.
    Leucht S; Kane JM; Etschel E; Kissling W; Hamann J; Engel RR
    Neuropsychopharmacology; 2006 Oct; 31(10):2318-25. PubMed ID: 16823384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Audio-digital recordings used for independent confirmation of site-based MADRS interview scores.
    Targum SD; Pendergrass JC; Toner C; Asgharnejad M; Burch DJ
    Eur Neuropsychopharmacol; 2014 Nov; 24(11):1760-6. PubMed ID: 25239474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia: A Systematic Review and Meta-analysis.
    Beck K; Hindley G; Borgan F; Ginestet C; McCutcheon R; Brugger S; Driesen N; Ranganathan M; D'Souza DC; Taylor M; Krystal JH; Howes OD
    JAMA Netw Open; 2020 May; 3(5):e204693. PubMed ID: 32437573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.
    Kane JM; Carson WH; Saha AR; McQuade RD; Ingenito GG; Zimbroff DL; Ali MW
    J Clin Psychiatry; 2002 Sep; 63(9):763-71. PubMed ID: 12363115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early improvement on antipsychotic treatment as a predictor of subsequent response in schizophrenia: analyses from ziprasidone clinical studies.
    O'Gorman C; Kapur S; Kolluri S; Kane J
    Hum Psychopharmacol; 2011; 26(4-5):282-90. PubMed ID: 21638329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical validation of ratings on the six-item Positive and Negative Syndrome Scale obtained via the Simplified Negative and Positive Symptoms Interview.
    Kølbæk P; Dines D; Holm T; Blicher AB; Sørensen RD; O'Leary KM; Feller SG; Buus CW; Nielsen CM; Opler M; Mors O; Correll CU; Østergaard SD
    J Psychopharmacol; 2021 Sep; 35(9):1081-1090. PubMed ID: 33779360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inter-rater reliability of ratings on the six-item Positive and Negative Syndrome Scale (PANSS-6) obtained using the Simplified Negative and Positive Symptoms Interview (SNAPSI).
    Kølbæk P; Blicher AB; Buus CW; Feller SG; Holm T; Dines D; O'Leary KM; Sørensen RS; Opler M; Correll CU; Mors O; Bech P; Østergaard SD
    Nord J Psychiatry; 2018 Aug; 72(6):431-436. PubMed ID: 30037286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Improvement As a Predictor of Later Response to Antipsychotics in Schizophrenia: A Diagnostic Test Review.
    Samara MT; Leucht C; Leeflang MM; Anghelescu IG; Chung YC; Crespo-Facorro B; Elkis H; Hatta K; Giegling I; Kane JM; Kayo M; Lambert M; Lin CH; Möller HJ; Pelayo-Terán JM; Riedel M; Rujescu D; Schimmelmann BG; Serretti A; Correll CU; Leucht S
    Am J Psychiatry; 2015 Jul; 172(7):617-29. PubMed ID: 26046338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ratings surveillance and reliability in a study of major depressive disorder with subthreshold hypomania (mixed features).
    Targum SD; Pendergrass JC; Lee S; Loebel A
    Int J Methods Psychiatr Res; 2018 Dec; 27(4):e1729. PubMed ID: 29943445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].
    Loas G; Noisette C; Legrand A; Delahousse J
    Encephale; 1997; 23(1):10-8. PubMed ID: 9172962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic efficacy of the antidepressant trimipramine: a randomized, double-blind comparison with the phenothiazine perazine.
    Bender S; Olbrich HM; Fischer W; Hornstein C; Schoene W; Falkai P; Haarmann C; Berger M; Gastpar M;
    Pharmacopsychiatry; 2003; 36(2):61-9. PubMed ID: 12734763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of findings in trials of antipsychotics: systematic review.
    Lepping P; Sambhi RS; Whittington R; Lane S; Poole R
    Br J Psychiatry; 2011 May; 198(5):341-5. PubMed ID: 21525517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial.
    Addington DE; Pantelis C; Dineen M; Benattia I; Romano SJ
    J Clin Psychiatry; 2004 Dec; 65(12):1624-33. PubMed ID: 15641867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
    Citrome L; Meng X; Hochfeld M; Stahl SM
    Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.